NOVOGEN 9 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHWed, 29 Apr 2026 02:57:42 +0200https://images.finanzen.net/images/finanzen_net_neu.gifNOVOGEN 9 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netKazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-EndThu, 08 Jan 2026 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-to-participate-in-j-p-morgan-healthcare-conference-week-clinical-and-translational-update-anticipated-before-month-end-15402245

SYDNEY, Jan. 8, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief ...

]]>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-to-participate-in-j-p-morgan-healthcare-conference-week-clinical-and-translational-update-anticipated-before-month-end-15402245Kazia Therapeutics Regains Full Nasdaq Listing ComplianceMon, 22 Dec 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-regains-full-nasdaq-listing-compliance-15374425

Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength

]]>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-regains-full-nasdaq-listing-compliance-15374425Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations inclu...Wed, 10 Dec 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-highlights-new-clinical-and-translational-findings-demonstrating-paxalisib-s-ability-to-reinvigorate-anti-tumor-immunity-across-multiple-advanced-breast-cancer-populations-inclu-15348855

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters

Reinvigoration of ...

]]>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-highlights-new-clinical-and-translational-findings-demonstrating-paxalisib-s-ability-to-reinvigorate-anti-tumor-immunity-across-multiple-advanced-breast-cancer-populations-inclu-15348855Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity SecuritiesTue, 02 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-announces-pricing-of-50-0-million-private-placement-of-equity-securities-15328382

SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused ...

]]>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-announces-pricing-of-50-0-million-private-placement-of-equity-securities-15328382Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory S...Tue, 18 Nov 2025 22:15:00 +0100https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-achieves-initial-icr-immune-complete-response-in-metastatic-tnbc-and-delivers-q4-business-update-with-breakthroughs-across-breast-cancer-immuno-oncology-and-gbm-regulatory-s-15289695

SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug ...

]]>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-achieves-initial-icr-immune-complete-response-in-metastatic-tnbc-and-delivers-q4-business-update-with-breakthroughs-across-breast-cancer-immuno-oncology-and-gbm-regulatory-s-15289695